e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pharmacological treatment in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Device type and real-world effectiveness of combination therapy
D. Price, M. Ali, A. Burden, A. Chisholm, L. Kemp, A. J. Lee, N. Roche, J. C. Virchow, J. von Zeigenweidt (Aberdeen, Norwich, United Kingdom; , France; Rostock, Germany)
Source:
Annual Congress 2010 - Pharmacological treatment in primary care
Session:
Pharmacological treatment in primary care
Session type:
Thematic Poster Session
Number:
846
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Price, M. Ali, A. Burden, A. Chisholm, L. Kemp, A. J. Lee, N. Roche, J. C. Virchow, J. von Zeigenweidt (Aberdeen, Norwich, United Kingdom; , France; Rostock, Germany). Device type and real-world effectiveness of combination therapy. Eur Respir J 2010; 36: Suppl. 54, 846
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 314s
Year: 2006
Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Impact of smart digital therapy feedback, motivation and assistance on CPAP adherence: a randomized-controlled trial
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
Comparison of efficacy and safety of fixed-dose combination regimen versus separate drugs for treatment of tuberculosis
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019
Monitoring adherence to treatment regimen of inhaled medication use in a clinical trial with an investigational eFlow nebulizer (eTrack)
Source: International Congress 2017 – Medical education, web and internet
Year: 2017
Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Eliminating in-vitro drug-drug interactions in dual and triple fixed-dose combination therapies using a novel cosuspension metered dose inhaler platform
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
IMPACT: Healthcare resource use data and associated costs for single-inhaler triple therapy versus dual therapies in Spain
Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence
Year: 2021
Cost consequences of tiotropium plus existing therapy
versus
existing therapy alone following one year of treatment in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001
One-year pulmonary safety and efficacy of inhaled insulin as adjunctive therapy in type 2 diabetes patients poorly controlled on oral agent monotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 618s
Year: 2004
Highly efficient dual and triple combination therapies with no coformulation effect for treatment of COPD
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012
Safety and effectiveness of flexible endobronchial cryotherapy as a diagnostic and concurrently therapeutic modality
Source: Annual Congress 2010 - Airway patency: the role of interventional bronchoscopy
Year: 2010
Effectiveness
versus
efficacy trials in COPD: how study design influences outcomes and applicability
Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017
Year: 2018
Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial
Source: Breathe, 17 (1) 200279; 10.1183/20734735.0279-2020
Year: 2021
Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning
Source: Eur Respir J, 54 (6) 1902111; 10.1183/13993003.02111-2019
Year: 2019
Dual bronchodilation vs triple therapy in the real-life DACCORD study
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018
Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease
Source: Eur Respir J 2003; 22: Suppl. 45, 474s
Year: 2003
The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Consistent benefit across multiple exacerbation endpoints
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept